I agree that this site is using cookies. You can find further informations here.
X
Wages, Nolan A.
164  results:
Search for persons X
?
1

Venetoclax with decitabine or azacitidine in relapsed or re..:

Bouligny, Ian M. ; Murray, Graeme ; Doyel, Michael...
Medical Oncology.  41 (2024)  3 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
2

Isotonic Phase I Cancer Clinical Trial Design Utilizing Pat..:

Wages, Nolan A. ; Lin, Ruitao
Statistics in Biopharmaceutical Research.  , 2024
Link: https://doi.org/10.1080/..
 
?
3

Applications of the partial-order continual reassessment me..:

Wages, Nolan A ; Dillon, Patrick M ; Portell, Craig A..
Clinical Trials.  21 (2024)  3 - p. 331-339 , 2024
Link: https://doi.org/10.1177/..
 
?
4

Current issues in dose-finding designs: A response to the U..:

Thall, Peter F ; Garrett-Mayer, Elizabeth ; Wages, Nolan A..
Clinical Trials.  21 (2024)  3 - p. 267-272 , 2024
Link: https://doi.org/10.1177/..
 
?
5

A Pilot Study of the Combination of Entinostat with Capecit..:

Millard, Trish ; Brenin, Christiana ; Humphrey, Clare...
International Journal of Breast Cancer.  2024 (2024)  - p. 1-6 , 2024
Link: https://doi.org/10.1155/..
 
?
6

SFU: Surface-Free Utility-Based Design for Dose Optimizatio..:

Zhang, Jingyi ; Wages, Nolan A. ; Lin, Ruitao
Statistics in Biosciences.  , 2024
Link: https://doi.org/10.1007/..
 
?
7

Local continual reassessment methods for dose finding and o..:

Zhang, Jingyi ; Yan, Fangrong ; Wages, Nolan A.
Statistical Methods in Medical Research.  32 (2023)  10 - p. 2049-2063 , 2023
Link: https://doi.org/10.1177/..
 
?
8

Dose-finding based on feasibility and late-onset toxicity i..:

Bagley, Evan M. ; Wages, Nolan A.
Journal of Biopharmaceutical Statistics.  34 (2023)  2 - p. 151-163 , 2023
Link: https://doi.org/10.1080/..
 
?
9

Isotonic design for phase I cancer clinical trials with lat..:

Wages, Nolan A. ; Braun, Thomas M. ; Conaway, Mark R.
Journal of Biopharmaceutical Statistics.  33 (2023)  3 - p. 357-370 , 2023
Link: https://doi.org/10.1080/..
 
?
10

Quasi-partial order continual reassessment method: Applying..:

O'Connell, Nathaniel S. ; Wages, Nolan A. ; Garrett-Mayer, Elizabeth
Contemporary Clinical Trials.  125 (2023)  - p. 107050 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Concurrent dose-finding of a novel cancer drug with and wit..:

Wages, Nolan A. ; Saleh, Ramy R. ; Braun, Thomas M.
Journal of Clinical and Translational Science.  7 (2023)  1 - p. , 2023
Link: https://doi.org/10.1017/..
 
?
12

Abbreviated venetoclax with decitabine or azacitidine in ac..:

Bouligny, Ian M. ; Murray, Graeme ; Ho, Thuy...
Leukemia Research.  134 (2023)  - p. 107370 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Venetoclax with decitabine or azacitidine in the first‐line..:

Bouligny, Ian M. ; Murray, Graeme ; Doyel, Michael...
eJHaem.  4 (2023)  2 - p. 381-392 , 2023
Link: https://doi.org/10.1002/..
 
?
14

Impact of dose feasibility on the conduct of phase I trials..:

Bagley, Evan M. ; Wages, Nolan A.
Contemporary Clinical Trials Communications.  25 (2022)  - p. 100877 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Relationship of dose to vascular target volumes and local f..:

Nelson, Bailey ; Barrord, Michelle ; Wang, Kyle...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
1-15